[{"address1": "1180 Seminole Trail", "address2": "Suite 495", "city": "Charlottesville", "state": "VA", "zip": "22901", "country": "United States", "phone": "434 422 9800", "website": "https://www.adialpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cary John Claiborne MBA", "age": 63, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 415076, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph A. M. Truluck M.B.A., MBA", "age": 45, "title": "CFO, Treasurer & Secretary", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": 279700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Goodman", "age": 59, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 59000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Bankole A. Johnson DSc, FRCPsych, M.D., M.Phil, Ph.D.", "age": 63, "title": "Founder & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 375000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John R. Martin J.D.", "title": "General Counsel", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Lugovoy", "title": "Chief Business Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack W. Reich Ph.D.", "age": 74, "title": "Head of Regulatory", "yearBorn": 1949, "fiscalYear": 2022, "totalPay": 17006, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark H. Peikin", "title": "Chief Strategy Officer & Chief Development Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Catherine  Fratila", "title": "Controller", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.74, "open": 1.74, "dayLow": 1.5, "dayHigh": 1.74, "regularMarketPreviousClose": 1.74, "regularMarketOpen": 1.74, "regularMarketDayLow": 1.5, "regularMarketDayHigh": 1.74, "beta": 1.524, "forwardPE": -1.0821918, "volume": 292615, "regularMarketVolume": 292615, "averageVolume": 4031319, "averageVolume10days": 1117510, "averageDailyVolume10Day": 1117510, "bid": 2.0, "ask": 2.07, "bidSize": 1100, "askSize": 2900, "marketCap": 2628203, "fiftyTwoWeekLow": 0.77, "fiftyTwoWeekHigh": 14.0, "fiftyDayAverage": 1.4782, "twoHundredDayAverage": 3.24765, "currency": "USD", "enterpriseValue": 1608530, "floatShares": 972229, "sharesOutstanding": 1663420, "sharesShort": 28100, "sharesShortPriorMonth": 21930, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.016900001, "heldPercentInsiders": 0.09802, "heldPercentInstitutions": 0.15911001, "shortPercentOfFloat": 0.018099999, "impliedSharesOutstanding": 1831870, "bookValue": 1.921, "priceToBook": 0.8224883, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -9582406, "trailingEps": -8.98, "forwardEps": -1.46, "lastSplitFactor": "1:25", "lastSplitDate": 1691366400, "enterpriseToEbitda": -0.158, "52WeekChange": -0.8495238, "SandP52WeekChange": 0.29495108, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ADIL", "underlyingSymbol": "ADIL", "shortName": "Adial Pharmaceuticals, Inc", "longName": "Adial Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1532698200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a144d6a7-1775-3bb1-b1ca-599a0edca1eb", "messageBoardId": "finmb_112638788", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.58, "targetHighPrice": 26.0, "targetLowPrice": 8.0, "targetMeanPrice": 17.0, "targetMedianPrice": 17.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 315880, "totalCashPerShare": 0.259, "ebitda": -10150964, "quickRatio": 1.261, "currentRatio": 2.15, "returnOnAssets": -1.197, "returnOnEquity": -2.47342, "freeCashflow": -4632171, "operatingCashflow": -7335125, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-03-17"}]